Analysis of medicinal product exports in the republic of Uzbekistan

The article examines the key aspects of pharmaceutical exports by manufacturers of the Republic of Uzbekistan. Particular attention is paid to analyzing the current state and development dynamics of the export potential of the pharmaceutical industry, identifying the main barriers, and exploring prospects for Uzbek pharmaceutical companies to enter foreign markets. The study considers government support measures, including export subsidies, simplification of certification procedures, as well as the role of international quality standards (GMP, GDP) in enhancing product competitiveness. Examples of successful export experiences of domestic manufacturers are provided, emphasizing the need for strategic planning, innovative development, and strengthening international relations to expand the geography of supplies.

The article presents a comprehensive analysis of the current state and trends in pharmaceutical exports from the Republic of Uzbekistan. The study showed that, despite a threefold increase in pharmaceutical production volumes and a sixfold growth in exports in recent years, the export activity of the industry remains structurally unstable. The main problems are the high concentration of exports in a limited range of products (mainly under HS code 3004900002), dependence on short-term contracts, and a decline in the average export price. The study also examines government support measures applied in Uzbekistan–both financial (subsidies and reimbursement of transportation costs, accreditation, tax incentives) and non-financial (simplification of certification and customs procedures, investment stimulation, support for export-oriented enterprises). Special attention is paid to changes in state policy related to aligning support measures with the requirements of the World Trade Organization. The results of the study indicate the need to shift from short-term incentive measures to a strategic approach, including diversification of the export portfolio, expansion of supply geography, and implementation of international GMP standards. The implementation of these directions will ensure sustainable development and increase the competitiveness of Uzbekistan’s pharmaceutical products in the global market.